Possible zoledronic acid-induced dermatomyositis

Clin Exp Dermatol. 2012 Apr;37(3):309-11. doi: 10.1111/j.1365-2230.2011.04198.x. Epub 2011 Oct 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Bone Density Conservation Agents / adverse effects*
  • Dermatomyositis / chemically induced*
  • Diphosphonates / adverse effects*
  • Female
  • Humans
  • Imidazoles / adverse effects*
  • Prednisolone / therapeutic use
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Anti-Inflammatory Agents
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
  • Prednisolone